Skip to main content
Clinical Trials/CTRI/2023/07/055665
CTRI/2023/07/055665
Not yet recruiting
未知

A Retrospective Study to Understand the Clinical Characteristics andthe Treatment Patterns For HR positive, HER2 negative High-Risk Early Breast CancerPatients - NI

Clinart MENA0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Sponsor
Clinart MENA
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Clinart MENA

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult women \>\=18 years of age (or per local regulations).
  • 2\. The participant has confirmed HR\+, HER2\-, early\-stage resected invasive breast cancer
  • without evidence of distant metastases.
  • 3\. The participant must have undergone definitive surgery of the primary breast tumor.
  • 4\. The participant must have tumor tissue from the breast (preferred) or lymph node.

Exclusion Criteria

  • 1\. Distant metastasis.
  • No other explicit exclusion criteria are defined to allow for documentation of routine clinical
  • practice as much as possible.

Outcomes

Primary Outcomes

Not specified

Similar Trials